CompletedNot Applicable

Relationship Between Skin Microbiome, Epigenetic Age, and Facial Features in Aging

France100 participantsStarted 2025-10-13

Plain-language summary

The goal of this observational study is to evaluate the effect of age on skin microbiome.

Age range25 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Healthy subject;
✓. Sex: female
✓. Age: 50% having between 25 to 35 years old or 50% between 55 to 65 years old
✓. Type: Caucasian
✓. Phototype: I to III on the Fitzpatrick scale
✓. Subject, having given freely and expressly her informed consent.
✓. Subject, psychologically able to understand the study related information and to give a written informed consent;
✓. Subject able to comply with protocol requirements;

✕. Pregnant or nursing woman or planning a pregnancy during the study;
✕. Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship;
✕. Subject who is under guardianship or who is not able to express her consent;
✕. Subject in a social or sanitary establishment;
✕. Subject suspected to be non-compliant according to the investigator's judgment;
✕. Subject having received 6000 euros indemnities for participation in a clinical research in the 12 previous months, including participation in the present study;
✕. Subject enrolled in another clinical trial or which exclusion period is not over.
✕. Subject with a condition or receiving a medication which, in the investigator's judgment, put the subject at undue risk or which may interfere with the evaluation;

Skin microbiome

Timeframe: single time point

NCT IDNCT07431203

SponsorLesaffre International

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-12-11

Who can participate

Age range25 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Healthy subject;
✓. Sex: female
✓. Age: 50% having between 25 to 35 years old or 50% between 55 to 65 years old
✓. Type: Caucasian
✓. Phototype: I to III on the Fitzpatrick scale
✓. Subject, having given freely and expressly her informed consent.
✓. Subject, psychologically able to understand the study related information and to give a written informed consent;
✓. Subject able to comply with protocol requirements;

✕. Pregnant or nursing woman or planning a pregnancy during the study;
✕. Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship;
✕. Subject who is under guardianship or who is not able to express her consent;
✕. Subject in a social or sanitary establishment;
✕. Subject suspected to be non-compliant according to the investigator's judgment;
✕. Subject having received 6000 euros indemnities for participation in a clinical research in the 12 previous months, including participation in the present study;
✕. Subject enrolled in another clinical trial or which exclusion period is not over.
✕. Subject with a condition or receiving a medication which, in the investigator's judgment, put the subject at undue risk or which may interfere with the evaluation;